CytomX Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for CytomX Therapeutics stock have an average target of 5.77, with a low estimate of 3.50 and a high estimate of 8.00. The average target predicts an increase of 561.09% from the current stock price of 0.87.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.50	$5.77	$8.00	$8.00
Change	+301.01%	+561.09%	+816.59%	+816.59%

* Price targets were last updated on May 28, 2024.

Analyst Ratings

The average analyst rating for CTMX stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	1	1
Buy	2	2	2	2	2	2
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 11, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Sep 13, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 22, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jun 27, 2024
Joseph Catanzaro Piper Sandler	Piper Sandler	Hold → Buy Upgrades $2.25 → $3.5	Hold → Buy	Upgrades	$2.25 → $3.5	+301.01%	May 28, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

113.15M

from 101.21M

11.79%

from 101.21M

Revenue Next Year

77.51M

from 113.15M

-31.50%

from 113.15M

EPS This Year

-0.27

from -0.01

EPS Next Year

-0.60

from -0.27

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	26.90M	68.43M	37.31M	53.16M	101.21M	113.15M	77.51M	34.35M
Revenue Growth	-54.79%	154.36%	-45.47%	42.48%	90.38%	11.79%	-31.50%	-55.68%
EPS	-2.93	-1.40	-1.81	-1.51	-0.01	-0.27	-0.60	-0.86
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	9	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	126.0M	107.1M	88.9M
Avg	113.2M	77.5M	34.3M
Low	83.0M	30.4M	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	24.5%	-5.3%	14.7%
Avg	11.8%	-31.5%	-55.7%
Low	-18.0%	-73.2%	-

EPS Forecast

EPS	2024	2025	2026
High	-0.02	-0.44	-0.46
Avg	-0.27	-0.60	-0.86
Low	-0.52	-0.93	-1.13

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.